Biomarkers of kidney disease
Clinical applications for biomarkers include monitoring illness activity, diagnosing it, managing molecularly targeted therapies, and monitoring therapy response. Glomerular filtration rate (GFR) continues to be the ideal indicator of renal health. Kidney damage atoms and lipocalin associated with neutrophil gelatinase are thought to be useful biomarkers in plasma and urine to assess the severity and prognosis of Chronic Kidney Disease.
- Decompensated heart failure
Related Conference of Biomarkers of kidney disease
October 29-30, 2026
14th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Paris, France